Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2021 | 64 | 3.820 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 14 | 2021 | 63 | 2.720 |
Why?
|
GATA3 Transcription Factor | 20 | 2016 | 152 | 2.660 |
Why?
|
Th2 Cells | 23 | 2019 | 1047 | 2.410 |
Why?
|
T-Lymphocytes, Helper-Inducer | 8 | 2021 | 973 | 1.430 |
Why?
|
Arthritis, Rheumatoid | 8 | 2023 | 3755 | 1.380 |
Why?
|
Interleukin-4 | 15 | 2016 | 1130 | 1.330 |
Why?
|
Cell Differentiation | 32 | 2021 | 11471 | 1.180 |
Why?
|
T-Lymphocyte Subsets | 11 | 2019 | 1807 | 1.060 |
Why?
|
Citrulline | 2 | 2016 | 106 | 1.040 |
Why?
|
Th1 Cells | 12 | 2013 | 1031 | 1.010 |
Why?
|
Thymus Gland | 8 | 2009 | 1244 | 0.880 |
Why?
|
Proto-Oncogene Proteins c-maf | 18 | 2015 | 69 | 0.800 |
Why?
|
DNA-Binding Proteins | 25 | 2019 | 9574 | 0.800 |
Why?
|
Trans-Activators | 12 | 2008 | 2860 | 0.790 |
Why?
|
Elastic Tissue | 1 | 2021 | 65 | 0.760 |
Why?
|
Lymphocyte Activation | 9 | 2012 | 5490 | 0.720 |
Why?
|
Natural Killer T-Cells | 2 | 2021 | 311 | 0.710 |
Why?
|
Gene Expression Regulation | 21 | 2022 | 11892 | 0.680 |
Why?
|
T-Lymphocytes | 15 | 2016 | 10171 | 0.600 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 500 | 0.590 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 17 | 2005 | 4485 | 0.560 |
Why?
|
DNA, Complementary | 4 | 2015 | 1991 | 0.540 |
Why?
|
Th17 Cells | 3 | 2019 | 785 | 0.540 |
Why?
|
NFATC Transcription Factors | 6 | 2013 | 381 | 0.530 |
Why?
|
Leukocytes, Mononuclear | 3 | 2021 | 1826 | 0.520 |
Why?
|
Promoter Regions, Genetic | 16 | 2015 | 5779 | 0.500 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 909 | 0.490 |
Why?
|
Hydrolases | 1 | 2015 | 146 | 0.480 |
Why?
|
Mice, Knockout | 27 | 2021 | 14354 | 0.470 |
Why?
|
Nuclear Proteins | 9 | 2004 | 5786 | 0.440 |
Why?
|
Mice | 56 | 2023 | 81101 | 0.440 |
Why?
|
Cytokines | 15 | 2016 | 7338 | 0.430 |
Why?
|
Recombinant Proteins | 3 | 2021 | 6520 | 0.420 |
Why?
|
Interleukin-2 | 4 | 2016 | 1888 | 0.420 |
Why?
|
Transcription Factors | 18 | 2013 | 12094 | 0.410 |
Why?
|
Proteins | 2 | 2023 | 6026 | 0.390 |
Why?
|
Animals | 65 | 2023 | 167768 | 0.380 |
Why?
|
Colitis | 4 | 2016 | 1229 | 0.380 |
Why?
|
Homeostasis | 3 | 2019 | 3301 | 0.370 |
Why?
|
Receptors, Antigen, T-Cell | 10 | 2008 | 2532 | 0.360 |
Why?
|
Disease | 1 | 2016 | 671 | 0.350 |
Why?
|
Interleukin-7 | 1 | 2010 | 142 | 0.350 |
Why?
|
Cell Polarity | 1 | 2013 | 638 | 0.350 |
Why?
|
Repressor Proteins | 5 | 2005 | 2980 | 0.340 |
Why?
|
Interleukin-13 | 4 | 2011 | 372 | 0.320 |
Why?
|
Mice, Transgenic | 17 | 2022 | 9518 | 0.320 |
Why?
|
Protein Processing, Post-Translational | 4 | 2023 | 1972 | 0.310 |
Why?
|
Alternative Splicing | 2 | 2012 | 1090 | 0.310 |
Why?
|
Enhancer Elements, Genetic | 7 | 2008 | 1356 | 0.300 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2796 | 0.290 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 435 | 0.280 |
Why?
|
Cell Lineage | 2 | 2009 | 2533 | 0.280 |
Why?
|
Autoantibodies | 1 | 2015 | 2118 | 0.270 |
Why?
|
Blotting, Western | 5 | 2014 | 5031 | 0.260 |
Why?
|
Cell Nucleus | 3 | 2015 | 2907 | 0.260 |
Why?
|
Molecular Sequence Data | 17 | 2013 | 17617 | 0.250 |
Why?
|
Down-Regulation | 4 | 2012 | 2904 | 0.250 |
Why?
|
Killer Cells, Natural | 3 | 2008 | 2201 | 0.240 |
Why?
|
Immunity, Innate | 3 | 2016 | 3047 | 0.240 |
Why?
|
Transcription, Genetic | 10 | 2010 | 7590 | 0.230 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2012 | 4549 | 0.220 |
Why?
|
Interleukin-10 | 7 | 2012 | 1174 | 0.220 |
Why?
|
Atrial Appendage | 1 | 2007 | 282 | 0.210 |
Why?
|
Macrophages | 3 | 2014 | 5737 | 0.210 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2008 | 4353 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2002 | 71 | 0.210 |
Why?
|
Syndecan-2 | 1 | 2022 | 23 | 0.200 |
Why?
|
Prosthesis Implantation | 1 | 2007 | 590 | 0.200 |
Why?
|
Protein Binding | 9 | 2015 | 9311 | 0.200 |
Why?
|
Milk Proteins | 1 | 2002 | 163 | 0.200 |
Why?
|
Mice, Inbred C57BL | 12 | 2015 | 22003 | 0.190 |
Why?
|
Feedback, Physiological | 1 | 2004 | 475 | 0.190 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2159 | 0.190 |
Why?
|
Receptors, Interleukin-2 | 1 | 2002 | 562 | 0.190 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 2009 | 899 | 0.180 |
Why?
|
Transcriptional Activation | 7 | 2015 | 1752 | 0.180 |
Why?
|
Introns | 2 | 2006 | 978 | 0.180 |
Why?
|
Echocardiography, Transesophageal | 1 | 2007 | 1088 | 0.180 |
Why?
|
Phospholipases A | 1 | 2001 | 204 | 0.180 |
Why?
|
Immunoglobulin A | 1 | 2023 | 979 | 0.170 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2015 | 1171 | 0.170 |
Why?
|
Mice, Inbred BALB C | 11 | 2012 | 6209 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2021 | 800 | 0.170 |
Why?
|
T-Box Domain Proteins | 4 | 2005 | 468 | 0.170 |
Why?
|
Signal Transduction | 9 | 2019 | 23342 | 0.170 |
Why?
|
Cloning, Molecular | 6 | 2004 | 4169 | 0.160 |
Why?
|
Interferon-gamma | 6 | 2008 | 3156 | 0.160 |
Why?
|
Proto-Oncogenes | 3 | 1999 | 320 | 0.160 |
Why?
|
Zinc Fingers | 3 | 2002 | 568 | 0.160 |
Why?
|
Base Sequence | 12 | 2013 | 12436 | 0.160 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2019 | 146 | 0.160 |
Why?
|
Alcohol Oxidoreductases | 1 | 2019 | 169 | 0.160 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1529 | 0.160 |
Why?
|
Intracellular Space | 1 | 2019 | 197 | 0.160 |
Why?
|
Transfection | 5 | 2014 | 5779 | 0.160 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2002 | 788 | 0.160 |
Why?
|
Amino Acid Sequence | 9 | 2010 | 13447 | 0.160 |
Why?
|
Ionomycin | 2 | 2008 | 109 | 0.150 |
Why?
|
Biological Assay | 1 | 2021 | 626 | 0.150 |
Why?
|
Humans | 48 | 2023 | 758406 | 0.150 |
Why?
|
Pulmonary Fibrosis | 1 | 2022 | 506 | 0.150 |
Why?
|
Respiratory Hypersensitivity | 1 | 2019 | 272 | 0.150 |
Why?
|
Integrases | 1 | 2020 | 516 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 424 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2014 | 7843 | 0.140 |
Why?
|
DNA, Catalytic | 1 | 2016 | 5 | 0.140 |
Why?
|
Phosphofructokinase-2 | 1 | 2016 | 32 | 0.140 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2008 | 818 | 0.140 |
Why?
|
Interleukins | 3 | 2015 | 783 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1066 | 0.140 |
Why?
|
Gene Targeting | 2 | 1999 | 837 | 0.130 |
Why?
|
Carrier Proteins | 1 | 2009 | 4938 | 0.130 |
Why?
|
Basophils | 2 | 2016 | 404 | 0.130 |
Why?
|
STAT6 Transcription Factor | 4 | 2011 | 193 | 0.130 |
Why?
|
Models, Biological | 1 | 2012 | 9460 | 0.130 |
Why?
|
Hypersensitivity | 3 | 2011 | 1155 | 0.130 |
Why?
|
Protein Isoforms | 2 | 2012 | 1694 | 0.130 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3069 | 0.120 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3432 | 0.120 |
Why?
|
Phosphotyrosine | 1 | 2015 | 455 | 0.120 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2015 | 330 | 0.110 |
Why?
|
Protein Structure, Tertiary | 3 | 2014 | 3796 | 0.110 |
Why?
|
Flow Cytometry | 4 | 2014 | 5864 | 0.110 |
Why?
|
Immune Tolerance | 2 | 2015 | 2297 | 0.110 |
Why?
|
Peptides, Cyclic | 1 | 2015 | 392 | 0.110 |
Why?
|
Interleukin-12 | 3 | 2006 | 583 | 0.110 |
Why?
|
Cells, Cultured | 11 | 2012 | 18940 | 0.110 |
Why?
|
src-Family Kinases | 1 | 2015 | 535 | 0.110 |
Why?
|
Spleen | 5 | 2006 | 2296 | 0.100 |
Why?
|
Up-Regulation | 5 | 2012 | 4113 | 0.100 |
Why?
|
Thrombosis | 1 | 2007 | 2929 | 0.100 |
Why?
|
Mice, Inbred ICR | 2 | 2004 | 364 | 0.100 |
Why?
|
Dextran Sulfate | 1 | 2013 | 255 | 0.100 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 577 | 0.100 |
Why?
|
Lymphocytes | 2 | 2016 | 2610 | 0.100 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2008 | 823 | 0.100 |
Why?
|
Adipocytes | 1 | 1998 | 1177 | 0.100 |
Why?
|
Mast Cells | 1 | 1999 | 1390 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2012 | 134 | 0.090 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 50 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2015 | 16886 | 0.090 |
Why?
|
Binding Sites | 7 | 2006 | 6036 | 0.090 |
Why?
|
Protein Transport | 2 | 2013 | 1963 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-ets | 4 | 2005 | 311 | 0.090 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2010 | 30 | 0.090 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 802 | 0.090 |
Why?
|
Luciferases | 1 | 2012 | 714 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 15773 | 0.090 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 68 | 0.090 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2009 | 57 | 0.090 |
Why?
|
Genes, Regulator | 1 | 1990 | 374 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2012 | 877 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2009 | 52 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 559 | 0.080 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2010 | 198 | 0.080 |
Why?
|
Ovalbumin | 2 | 2008 | 673 | 0.080 |
Why?
|
Isoenzymes | 1 | 2014 | 1686 | 0.080 |
Why?
|
3T3 Cells | 2 | 2002 | 1084 | 0.080 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2008 | 25 | 0.080 |
Why?
|
Female | 17 | 2019 | 390323 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2019 | 2868 | 0.080 |
Why?
|
Lymphopoiesis | 1 | 2009 | 133 | 0.080 |
Why?
|
Middle Aged | 7 | 2021 | 219568 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1557 | 0.080 |
Why?
|
Conserved Sequence | 2 | 2009 | 1165 | 0.080 |
Why?
|
Atrial Fibrillation | 1 | 2007 | 5103 | 0.080 |
Why?
|
Interleukin-12 Subunit p40 | 2 | 2005 | 57 | 0.070 |
Why?
|
Kinetics | 2 | 2008 | 6371 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2204 | 0.070 |
Why?
|
Leucine Zippers | 2 | 2004 | 116 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4342 | 0.070 |
Why?
|
Proteomics | 1 | 2021 | 3816 | 0.070 |
Why?
|
Monocytes | 2 | 2015 | 2570 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2816 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2007 | 79 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3801 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1969 | 0.070 |
Why?
|
GATA4 Transcription Factor | 1 | 2008 | 124 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1120 | 0.070 |
Why?
|
CD40 Ligand | 1 | 2008 | 519 | 0.070 |
Why?
|
NF-kappa B | 3 | 2005 | 2472 | 0.070 |
Why?
|
Tumor Cells, Cultured | 3 | 2002 | 6127 | 0.070 |
Why?
|
Interleukin-3 | 1 | 2008 | 425 | 0.070 |
Why?
|
Galactosylceramides | 1 | 2006 | 92 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2008 | 1751 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2008 | 3485 | 0.070 |
Why?
|
Retinoid X Receptors | 1 | 2006 | 91 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2001 | 2262 | 0.070 |
Why?
|
Proline | 1 | 2008 | 456 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 64378 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2416 | 0.060 |
Why?
|
Lung | 3 | 2022 | 9985 | 0.060 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1998 | 221 | 0.060 |
Why?
|
Methionine | 1 | 2008 | 569 | 0.060 |
Why?
|
Antigen Presentation | 2 | 2008 | 1254 | 0.060 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2006 | 503 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2009 | 3071 | 0.060 |
Why?
|
Male | 11 | 2016 | 358747 | 0.060 |
Why?
|
Interleukin-17 | 2 | 2008 | 908 | 0.060 |
Why?
|
Aged | 6 | 2021 | 168218 | 0.060 |
Why?
|
Leukotrienes | 1 | 2006 | 231 | 0.060 |
Why?
|
Exons | 2 | 2007 | 2387 | 0.060 |
Why?
|
Immunoblotting | 2 | 2002 | 1647 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2006 | 1378 | 0.060 |
Why?
|
Pneumonia | 2 | 2006 | 2129 | 0.060 |
Why?
|
Protein Subunits | 2 | 2005 | 942 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2008 | 735 | 0.060 |
Why?
|
Epidermis | 1 | 2006 | 528 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2002 | 1894 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2008 | 1734 | 0.050 |
Why?
|
Antibodies | 2 | 2008 | 2420 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2016 | 12759 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20055 | 0.050 |
Why?
|
STAT4 Transcription Factor | 1 | 2002 | 93 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2564 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2004 | 751 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2016 | 18119 | 0.050 |
Why?
|
Restriction Mapping | 3 | 1999 | 852 | 0.050 |
Why?
|
Angiotensin II | 1 | 2005 | 848 | 0.050 |
Why?
|
Gene Deletion | 2 | 2008 | 2666 | 0.050 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 24 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2019 | 4257 | 0.050 |
Why?
|
Phylogeny | 1 | 2009 | 2774 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2010 | 2176 | 0.050 |
Why?
|
Apoptosis | 4 | 2008 | 9468 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1533 | 0.050 |
Why?
|
Cell Line | 6 | 2010 | 15591 | 0.050 |
Why?
|
Phosphorylation | 2 | 2015 | 8297 | 0.050 |
Why?
|
Two-Hybrid System Techniques | 2 | 2015 | 458 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4567 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5862 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2002 | 263 | 0.050 |
Why?
|
Cell Survival | 3 | 2007 | 5781 | 0.050 |
Why?
|
Sp1 Transcription Factor | 1 | 2022 | 140 | 0.050 |
Why?
|
DNA | 6 | 2000 | 7199 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2007 | 878 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1611 | 0.050 |
Why?
|
Cysteine | 1 | 2006 | 893 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2016 | 22029 | 0.050 |
Why?
|
Cell Division | 3 | 2004 | 4458 | 0.050 |
Why?
|
Bleomycin | 1 | 2022 | 495 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1404 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1958 | 0.050 |
Why?
|
Fibrosarcoma | 1 | 2002 | 308 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2008 | 10416 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2001 | 240 | 0.040 |
Why?
|
Immunoglobulins | 2 | 2006 | 859 | 0.040 |
Why?
|
COS Cells | 1 | 2002 | 1128 | 0.040 |
Why?
|
Genetic Loci | 1 | 2009 | 2612 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29557 | 0.040 |
Why?
|
Calcium | 1 | 2013 | 5721 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2057 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2000 | 4624 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2007 | 2105 | 0.040 |
Why?
|
Adult | 5 | 2019 | 219935 | 0.040 |
Why?
|
Mice, SCID | 1 | 2005 | 2626 | 0.040 |
Why?
|
COP-Coated Vesicles | 1 | 2019 | 39 | 0.040 |
Why?
|
HeLa Cells | 2 | 2019 | 3096 | 0.040 |
Why?
|
Crystallins | 1 | 1999 | 75 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2825 | 0.040 |
Why?
|
Precipitin Tests | 1 | 2000 | 814 | 0.040 |
Why?
|
Starvation | 1 | 2019 | 140 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3733 | 0.040 |
Why?
|
Interleukin-5 | 3 | 2006 | 269 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5427 | 0.040 |
Why?
|
Fetus | 2 | 2002 | 1859 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2006 | 1895 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1915 | 0.040 |
Why?
|
Species Specificity | 1 | 2002 | 2417 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2004 | 1353 | 0.040 |
Why?
|
Aorta | 1 | 2005 | 2037 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2019 | 655 | 0.040 |
Why?
|
Administration, Rectal | 1 | 2016 | 70 | 0.030 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2016 | 64 | 0.030 |
Why?
|
Oxazolone | 1 | 2016 | 61 | 0.030 |
Why?
|
Lens, Crystalline | 1 | 1999 | 388 | 0.030 |
Why?
|
Liver | 2 | 2002 | 7502 | 0.030 |
Why?
|
DNA Footprinting | 1 | 1996 | 97 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16534 | 0.030 |
Why?
|
Cyclosporine | 1 | 1998 | 777 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2016 | 256 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 1996 | 555 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2007 | 3072 | 0.030 |
Why?
|
NAD | 1 | 2019 | 609 | 0.030 |
Why?
|
Inflammation | 2 | 2005 | 10718 | 0.030 |
Why?
|
Response Elements | 2 | 2009 | 308 | 0.030 |
Why?
|
Biological Transport | 1 | 2019 | 2084 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2009 | 8506 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1996 | 1543 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 346 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2005 | 2723 | 0.030 |
Why?
|
Gene Library | 1 | 1996 | 1059 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2443 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6850 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6068 | 0.030 |
Why?
|
Clone Cells | 1 | 1996 | 1660 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2858 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 58808 | 0.030 |
Why?
|
Strongylida Infections | 1 | 2011 | 48 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17768 | 0.020 |
Why?
|
Fibroblasts | 1 | 2022 | 4087 | 0.020 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1991 | 195 | 0.020 |
Why?
|
Gene Expression | 3 | 2011 | 7583 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2009 | 21017 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 6157 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
Neoplastic Stem Cells | 2 | 2009 | 1346 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10748 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 1991 | 296 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1990 | 777 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8945 | 0.020 |
Why?
|
Immunoglobulin Constant Regions | 1 | 1989 | 58 | 0.020 |
Why?
|
Asthma | 1 | 2008 | 6172 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 73809 | 0.020 |
Why?
|
Cell Membrane | 1 | 1999 | 3680 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1990 | 1141 | 0.020 |
Why?
|
Crohn Disease | 2 | 2016 | 2275 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 1989 | 285 | 0.020 |
Why?
|
B-Lymphocytes | 2 | 2006 | 4738 | 0.020 |
Why?
|
Interleukin-9 | 1 | 2008 | 61 | 0.020 |
Why?
|
Colon | 1 | 2016 | 1787 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 1989 | 419 | 0.020 |
Why?
|
U937 Cells | 1 | 2008 | 262 | 0.020 |
Why?
|
Animals, Newborn | 2 | 2006 | 2672 | 0.020 |
Why?
|
Multigene Family | 1 | 1991 | 1076 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2009 | 203 | 0.020 |
Why?
|
Chickens | 1 | 2009 | 860 | 0.020 |
Why?
|
Keratin-13 | 1 | 2006 | 11 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 305 | 0.020 |
Why?
|
Lymphoma | 1 | 1996 | 1896 | 0.020 |
Why?
|
Hemolysis | 1 | 1989 | 423 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2010 | 616 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 2008 | 271 | 0.020 |
Why?
|
Biological Evolution | 1 | 1992 | 1074 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2008 | 819 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2001 | 3432 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2010 | 2753 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1990 | 685 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1990 | 1387 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3020 | 0.020 |
Why?
|
Lysine | 1 | 2010 | 998 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2009 | 555 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39059 | 0.020 |
Why?
|
Dogs | 1 | 2009 | 3840 | 0.020 |
Why?
|
Hyperplasia | 1 | 2008 | 1154 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 358 | 0.010 |
Why?
|
Stroke | 1 | 2007 | 9694 | 0.010 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2005 | 278 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2016 | 1919 | 0.010 |
Why?
|
Plasmids | 1 | 1989 | 2275 | 0.010 |
Why?
|
L-Selectin | 1 | 2004 | 209 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2013 | 0.010 |
Why?
|
Cattle | 1 | 2009 | 3845 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 1355 | 0.010 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2002 | 21 | 0.010 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 824 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 604 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 691 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 964 | 0.010 |
Why?
|
Nucleoproteins | 1 | 2002 | 113 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3082 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1990 | 4106 | 0.010 |
Why?
|
Clostridium Infections | 1 | 1989 | 557 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9160 | 0.010 |
Why?
|
Molecular Structure | 1 | 2006 | 1866 | 0.010 |
Why?
|
Embryonic Development | 1 | 2006 | 716 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 58683 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2006 | 1083 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2009 | 1885 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1996 | 14641 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1674 | 0.010 |
Why?
|
Allergens | 1 | 2008 | 1402 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3774 | 0.010 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2001 | 139 | 0.010 |
Why?
|
Kidney | 2 | 2010 | 7016 | 0.010 |
Why?
|
Eosinophils | 1 | 2004 | 946 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2002 | 552 | 0.010 |
Why?
|
Tissue Plasminogen Activator | 1 | 2005 | 1156 | 0.010 |
Why?
|
Genomic Library | 1 | 1999 | 189 | 0.010 |
Why?
|
HLA-DP Antigens | 1 | 1998 | 28 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 1998 | 119 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 622 | 0.010 |
Why?
|
Transgenes | 1 | 2001 | 1007 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4901 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2001 | 1825 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1989 | 1926 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 1998 | 778 | 0.010 |
Why?
|
Stem Cells | 1 | 2009 | 3521 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2008 | 3664 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5201 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2005 | 3208 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2004 | 2413 | 0.010 |
Why?
|
Sepsis | 1 | 1989 | 2587 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2001 | 1345 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11070 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13961 | 0.010 |
Why?
|
Pancreatitis | 1 | 2001 | 1098 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23679 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1999 | 1484 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9404 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13468 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2008 | 6313 | 0.010 |
Why?
|
Blood Pressure | 1 | 2005 | 8451 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1743 | 0.010 |
Why?
|
Clostridium perfringens | 1 | 1989 | 28 | 0.010 |
Why?
|
Methylation | 1 | 1992 | 1080 | 0.010 |
Why?
|
Child | 1 | 2016 | 79818 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 87892 | 0.000 |
Why?
|
Cholecystitis | 1 | 1989 | 181 | 0.000 |
Why?
|
Mutation | 1 | 1990 | 29915 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2001 | 5816 | 0.000 |
Why?
|
Aging | 1 | 1999 | 8650 | 0.000 |
Why?
|